-
Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock
-
Notable Analyst Rating Changes 7/22: (AMZN) (AUY) (JCP) Upgraded; (ABG) (UTC) (CHK) Downgraded
-
Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)
-
Roth Capital Starts Pieris Pharmaceuticals (PIRS) at Buy
-
Pieris Pharmaceuticals Closes Public Offering of Common Stock
-
Pieris Pharma (PIRS) Prices 9.1M Common Stock Offering at $2.75/Share
-
Pieris Pharmaceuticals Prices Public Offering of Common Stock